首页> 外国专利> Process for differentiation of cardiovascular cells from induced pluripotent stem cells prepared by human circulation multipotent adult stem cellsCiMS and uses thereof

Process for differentiation of cardiovascular cells from induced pluripotent stem cells prepared by human circulation multipotent adult stem cellsCiMS and uses thereof

机译:从人循环多能成体干细胞CiMS制备的诱导多能干细胞中分化心血管细胞的方法及其用途

摘要

The present invention relates to a method for producing pluripotent pluripotent stem cells derived from endocardial derived adult stem cells isolated from peripheral blood, a method for differentiating into pluripotent stem cells from the pluripotent pluripotent stem cells prepared by the method, and uses thereof.The intracardiac-derived adult stem cells, which are the primary cultured cells for the production of the induced pluripotent stem cells of the present invention, can be easily isolated and cultured even with a small amount of peripheral blood, can be stored without genetic mutation since they have high proliferation power, The number of cells that can be used can be quickly secured. In addition, since stem cells have stem cells, the production efficiency of induced pluripotent stem cells through the transduction of 4 kinds of Yamanaka factor is higher than that of conventional skin fibroblasts, and since they have endocardial origin, Since it has memory, induction pluripotent stem cells can be produced and then differentiated into cardiovascular cells such as endothelial cells, smooth muscle cells and myocardial cells with high efficiency. Therefore, the cardiovascular cells differentiated from the induced pluripotent stem cells can be used for library screening of a therapeutic substance for the development of a specific cardiovascular disease drug, and for studying the mechanism of cardiovascular diseases, It is expected to be widely used in various fields such as the use as a cell therapy agent by injecting again.
机译:本发明涉及一种从外周血中分离出的心内膜衍生成年干细胞衍生的多能多能干细胞的生产方法,由该方法制备的多能多能干细胞分化为多能干细胞的方法及其用途。来源的成体干细胞是用于产生本发明的诱导性多能干细胞的主要培养细胞,即使具有少量外周血也可以容易地分离和培养,由于它们具有高增殖能力,可以快速确保可以使用的细胞数量。另外,由于干细胞具有干细胞,因此通过4种山中因子的转导诱导的多能干细胞的生产效率高于常规皮肤成纤维细胞,并且由于它们具有心内膜起源,因此具有记忆力,因此诱导多能可以产生干细胞,然后将其高效分化为心血管细胞,例如内皮细胞,平滑肌细胞和心肌细胞。因此,从诱导的多能干细胞中分化出来的心血管细胞可用于筛选用于开发特定心血管疾病药物的治疗物质,并用于研究心血管疾病的机理,预期将其广泛用于各种疾病中。领域,例如通过再次注射用作细胞治疗剂。

著录项

  • 公开/公告号KR101781693B1

    专利类型

  • 公开/公告日2017-09-26

    原文格式PDF

  • 申请/专利权人 서울대학교병원;

    申请/专利号KR20150135715

  • 发明设计人 김효수;양한모;김주영;이주은;

    申请日2015-09-24

  • 分类号C12N5/074;A61K35/12;C12N5/071;C12N5/077;

  • 国家 KR

  • 入库时间 2022-08-21 13:24:48

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号